Engineering SARS-CoV-2 cocktail antibodies into a bispecific format improves neutralizing potency and breadth
Z. Ku, X. Xie, J. Lin, P. Gao, A. E. Sahili, H. Su, Y. Liu, X. Ye, X. Li, X. Fan, B. C. Goh, W. Xiong, H. Boyd, A. E. Muruato, H. Deng, , Z. An
This study engineers bispecific antibodies against SARS-CoV-2, showing that one design outperforms a cocktail in neutralizing activity and breadth against variants.
bioRxiv · Feb 1, 2022 · PreprintMicrobiology